Long-Term Liabilities: The sum of all non-current liabilities.
Stagezero Life Sciences Ltd. (SZLSF) had Long-Term Liabilities of $1.18M for the most recently reported fiscal year, ending 2022-12-31.
| Income Statement Financials | |
$3.80M |
|
$-11.42M |
|
$4.20M |
|
$-0.40M |
|
$11.54M |
|
$-7.75M |
|
$-3.67M |
|
$-11.42M |
|
$-4.05M |
|
$-11.42M |
|
$-11.42M |
|
$-11.42M |
|
$-4.05M |
|
$-7.75M |
|
$-7.51M |
|
99.43M |
|
99.43M |
|
$-0.11 |
|
$-0.11 |
|
| Balance Sheet Financials | |
$0.27M |
|
$0.43M |
|
$0.43M |
|
$0.70M |
|
$7.03M |
|
$0.58M |
|
|
Long-Term Liabilities |
$1.18M |
$8.20M |
|
$-7.50M |
|
$-7.50M |
|
$-7.50M |
|
105.47M |
|
| Cash Flow Statement Financials | |
$-3.53M |
|
-- |
|
$1.83M |
|
$1.72M |
|
$0.02M |
|
$-1.71M |
|
$0.24M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.04 |
|
-- |
|
-- |
|
-0.08 |
|
-0.21 |
|
-10.64% |
|
-204.13% |
|
-204.13% |
|
-197.81% |
|
-300.79% |
|
-300.79% |
|
$-3.53M |
|
-- |
|
-- |
|
-- |
|
5.42 |
|
43.91 |
|
121.47 |
|
3.00 |
|
152.14% |
|
152.14% |
|
-1629.25% |
|
164.80% |
|
$-0.07 |
|
$-0.04 |
|
$-0.04 |
|